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Arterial spin labelling (ASL)
Dual echo fMRICerebral blood ﬂow (CBF) is maintained despite changing systemic blood pressure through cerebral vascular
control, with such tight regulation believed to be under local tissue control. Chronic fatigue syndrome (CFS)
associates with a wide range of symptoms, including orthostatic intolerance, skeletal muscle pH abnormali-
ties and cognitive impairment. CFS patients are known to have reduced CBF and orthostatic intolerance asso-
ciates with abnormal vascular regulation, while skeletal muscle pH abnormalities associate with autonomic
dysfunction. These ﬁndings point to autonomic dysfunction as the central feature of CFS, and cerebral vascu-
lar control being inﬂuenced by factors outside of the brain, a macroscopic force affecting the stability of re-
gional regulation. We therefore explored whether there was a physiological link between cerebral vascular
control and skeletal muscle pH management in CFS.
Seventeen consecutive CFS patients fulﬁlling the Fukuda criteria were recruited from our local CFS clinical
service. To probe the static scenario, CBF and skeletal muscle pH were measured at rest using MRI and 31P
magnetic resonance spectroscopy (31P-MRS).
To examine dynamic control, brain functional MRI was performed concurrently with Valsalva manoeuvre (VM),
a standard autonomic function challenge, while 31P-MRS was performed during plantar ﬂexion exercise.
Signiﬁcant inverse correlation was seen between CBF and skeletal muscle pH at rest (r=−0.67, pb0.01).
Prolonged cerebral vascular constriction during the sympathetic phase of VM was associated with higher
pH in skeletal muscle after plantar ﬂexion exercise (r=0.69, pb0.008).
In conclusion, cerebral vascular control is closely related to skeletal muscle pH both at rest and after dynamic
stimulation in CFS.
© 2013 The Authors. Published by Elsevier Inc. Open access under CC BY license.1. Introduction
Cerebral blood ﬂow (CBF) is maintained at a constant level across
a range of blood pressure (BP) (Lassen, 1964). Although the cerebral
vascular control mechanism is local in healthy subjects, it is affected
by conditions such as hypertension (Immink et al., 2004) and chronic
fatigue syndrome (CFS) (Sutcliffe et al., 2010).
Although CFS (Evengard et al., 1999; Sanders and Korf, 2008) is classi-
ﬁed as a nervous system disease, its cause is unknown, and a number ofce Centre, Newcastle University,
44 191 2481150; fax: +44 191
nc. Open access under CC BY license.factors have been shown to be related to the disease progression (Afari
and Buchwald, 2003). Almost 90% of CFS patients describe orthostatic
symptoms (Newton et al., 2007) and autonomic dysfunction is a frequent
ﬁnding (Hollingsworth et al., 2010a). CFS patients have reduced CBF
(Biswal et al., 2011) and orthostatic intolerance is associated with
prolonged cerebral vascular constriction after autonomic challenge (Lin
et al., 2011). In our own studies, we have shown effects in peripheral tis-
sue including compromised skeletal muscle response to exercise, with
CFS patients generating higher levels of acid within their muscle com-
pared to matched sedentary controls (Hollingsworth et al., 2010a; Jones
et al., 2010). We have also already conﬁrmed that those CFS patients
with the skeletal muscle abnormality were signiﬁcantly more likely to
have concurrent impaired cardiac energetics (Hollingsworth et al.,
2012) and that the impairment of skeletal muscle pH handling correlates
with the autonomic dysfunction (Jones et al., 2010). In combination, this
data suggests that autonomic dysfunction is a central feature of CFS, in-
dictable by pH handling measurement in skeletal muscle.
Given its local nature, we hypothesise that cerebral vascular con-
trol in CFS is affected by autonomic dysfunction, and this relationship
169J. He et al. / NeuroImage: Clinical 2 (2013) 168–173would manifest itself in a correlation between the pH handling in
skeletal muscle and cerebral vascular control.
To test our hypothesis in a resting state we performed arterial spin
labelling (ASL) magnetic resonance imaging (MRI) to measure CBF in
the brain and used 31P magnetic resonance spectroscopy (MRS) to
probe skeletal muscle pH.
The Valsalva manoeuvre (VM) has been widely used to identify
deﬁcits in autonomic and cardiac function (Remmen et al., 2006;
Woo et al., 2007) as it induces phased changes in BP (Dawson et al.,
1999) (Fig. 1b). In particular, sympathetic function is characterised
by a rapid increase in BP at the end of the VM (marked “x” in
Fig. 1b). The vascular dilation associated with sympathetic function
can be detected by functional MRI (fMRI), tailored to reﬂect transient
changes in blood volume (Glover et al., 1996). Plantar ﬂexion exercise
demonstrated a skeletal muscle pH handling abnormality in CFS pa-
tients (Jones et al., 2010). The recovery of pH in skeletal muscle
after exercise is assisted by modulated blood ﬂow through changing
vascular calibre, a factor inﬂuenced by the autonomic function.
To examine the relationship between cerebral vascular control
and skeletal muscle pH handling in response to dynamic stimulation,
we explored the relationship between cerebral vascular parameters
during the VM through fMRI and skeletal muscle pH during plantar
ﬂexion exercise through 31P MRS.
2. Methods
Seventeen consecutive CFS patients were recruited from the local
CFS clinical service based at the Newcastle upon Tyne Hospitals NHS
Foundation Trust. All participants fulﬁlled the CDC 1994 (Fukuda) diag-
nostic criteria for CFS (Fukuda et al., 1994). The studywas reviewed and
approved by theNewcastle andNorth Tyneside Local Ethics Committee.Fig. 1. Shows (a) the schematic paradigm of the fMRI experiment, (b) the schematic diagr
phases of Valsalva manoeuvre, and (c) the group mean of cycle averaged time course meas
1 min cycles. Each cycle was composed of 16 s Valsalva manoeuvre and 44 s rest. The BP
“I”, “II”, “III” and “IV”. The characteristic peak associated with sympathetic function is mark
dividual time courses were normalised to their respective baseline signal level to derive the
while its duration is marked by the grey window. For each time course, the peak associated w
magnitude (solid line) measured.The sponsor was Newcastle upon Tyne Hospitals NHS Foundation Trust
and all participants provided written informed consent prior to the ex-
periment. The study was performed on a 3 T whole body MR scanner
(Achieva, Philips Medical Systems, The Netherlands). Two separate ap-
pointments weremade for each patient to look at the brain and skeletal
muscle, with a median time gap of 18 days.
2.1. Brain imaging
All the brain scans were performed in a single session for each pa-
tient using an 8 channel SENSE coil. Scans included 3D T1 weighted
anatomical images, resting CBF maps and dynamic imaging of the
VM in a functional MRI study.
2.1.1. Anatomical images
Anatomical images in sagittal orientation were acquired using a
standard T1 weighted clinical protocol with a resolution of
1×1×1.2 mm3, ﬁeld of view (FOV) of 240×240×216 mm3, repeti-
tion time (TR) of 8.1 ms and echo time (TE) of 4.6 ms. Segmentation
in SPM8 (Frackowiak, 2004) was performed on the anatomical im-
ages to generate patient speciﬁc grey matter masks.
2.1.2. Resting CBF mapping
Resting CBF was measured using an arterial spin labelling (ASL)
based sequence (Kim, 1995; He and Blamire, 2010), with spiral readout
module, TE of 11.13 ms, TR of 4 s, 4×4 mm2 in-plane resolution, FOV of
256×256 mm2, 30 averages and inﬂow time of 1500 ms. The image
volume covered 14 contiguous slices of 6 mm thickness, whichwas po-
sitioned parallel to the anterior commissure (AC)–posterior commis-
sure (PC) line and centred at the corpus callosum. Images were
processed in SPM8 to correct for patient movement (Frackowiak,am illustrating the mean arterial blood pressure (MABP) time course during the four
ured in fMRI experiment. The fMRI paradigm was composed of 30 s baseline and four
response is divided into four phases, each labelled in different shades and marked as
ed by “x”. The fMRI protocol monitors a signal related to cerebral vascular dilation. In-
percentage change time course. The onset of the Valsalva manoeuvre is aligned to 0 s,
ith sympathetic function, marked by “x”, was identiﬁed, with its time (dotted line) and
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was applied to the perfusion weighted images, and subsequently the
grey matter CBF was quantiﬁed (Kim and Tsekos, 1997).
2.1.3. Functional MRI
To investigate the effect of the Valsalva manoeuvre (VM) on the ce-
rebral circulation, subjects underwent a stimulus paradigm consisting
of a 30 s baseline period followed by four 1 min cycles each comprising
of a 16 s duration VM followed by a 44 s rest period (Fig. 1a). The phys-
iological responses (Fig. 1b) to the VM have four phases (Dawson et al.,
1999; Stolz et al., 2010): (I) onset of the initial strain increases intratho-
racic pressure and pulmonary blood is forced into the left atrium to in-
crease cardiac stroke volume andmean arterial blood pressure (MABP);
(II) due to reduced venous return, the stroke volume decreases causing
transient reduction in MABP until sympathetic activation induces vas-
cular constriction causingMABP and heart rate to rise; (III) immediately
after releasing the breathing pressure, the reduced pressure in the chest
induces a reduction in stroke volume and further vascular constriction;
(IV) with unimpeded venous return, cardiac output increases rapidly
and rises above normal levels, before returning to the resting condition
under the sympathetic control. Functional MRI used a dual echo time
(TE) gradient echo EPI sequence to characterise the brain response to
VM. An imaging volume was selected parallel to the AC–PC line and
centred at the anterior part of the corpus callosum (20 slices, 4 mm
thickness, 2.1×2.1 mm2 in-plane resolution, 112×112 matrix size, TR
of 2 s, TE of 14.0 ms and 39.2 ms). This method provided two levels of
sensitivity to the cerebrovascular response, with the short echo time
signal considered in this report being mainly sensitive to the tissue
water density (data from the second echo not reported here). Transient
changes in this signal during stimulation reﬂect the vascular dilation
(Glover et al., 1996). An air pressure monitoring system was employed
to measure performance of the VM, consisting of a mouthpiece
(POWERbreath, HaB direct, UK) adapted with a 30 ml Luer lock syringe
and anti bacterial air ﬁlter (AlbertWaeschle, UK) and connected via ox-
ygen tubing to a purpose built electronic air pressure meter. Instruc-
tions to begin and end each VM were visually presented to the subject
in the scanner via a projection system. During the VM, subjects were
instructed to maintain an exhaled air pressure of 40 mm Hg and were
presented with real-time pressure feedback which was marked out as
a target line on the visual display. Functional MRI time series data
were processed in SPM8 to extract the time course of the signal
changes.Within the dataset for each subject, all scanswere aligned, spa-
tially smoothed using an 8 mm full width at half maximum (FWHM)
Gaussian kernel and co-registeredwith anatomical images usingdefault
conﬁgurations (Frackowiak, 2004). The grey matter mask, generated
from the anatomical images, was then applied as a global region of in-
terest and the average time courses extracted. Each time course was
subsequently smoothed and interpolated to 0.1 s temporal resolution
using a spline algorithm (De Boor, 1978). Average fMRI responses to
the VMwere created for each individual subject. To correct for response
variations, the onset of each individual VM was deﬁned as the time
point at which the air pressure reached 5 mm Hg (based on the
recorded air pressure trace). A time course of 40 s duration was
extracted for each cycle, starting at the detected onset time and the 4
responses averaged. The cycle averaged time courses were then
normalised to the baseline signal level to obtain percentage change
time courses. The timing and magnitude of the recovery peak were
measured (marked by ‘x’ in Fig. 1c).
2.2. Muscle MR spectroscopy
MRS data acquisition was performed on a different day to brain im-
aging, to avoid potential physiological interference between the
Valsalva manoeuvre and skeletal muscle exercise. MRS data acquisition
and quantiﬁcation (Kemp and Radda, 1994; Kemp et al., 1997;
Vanhamme et al., 1999) were performed in the same manner as ourprevious work (Hollingsworth et al., 2008). The exercise protocol
(Fig. 2a) comprised a 180 s baseline followed by two 570 s long exer-
cise cycles interspersed by a 120 s rest period. Each exercise cycle
contained 180 s plantar ﬂexion with a ﬁxed load of 35% of the maxi-
mum voluntary contraction (Hollingsworth et al., 2008) and a 390 s re-
covery period. Resting muscle pH was measured from spectra acquired
during the pre-exercise baseline period (marked as “Baseline” in
Fig. 2a). Post exercise recovered pH was measured from the second
plantarﬂexion cycle (marked as “Post-Ex” in Fig. 2a),with theﬁrst plan-
tar ﬂexion cycle performed to remove muscular adaptation effects
(Hollingsworth et al., 2010b; Jones et al., 2012).
2.3. Statistical analysis
Statistical analysis was performed using SPSS statistical software
(Version 19, IBM, New York, USA). To examine the relationship be-
tween baseline CBF and pH in the skeletal muscle at rest, linear re-
gression (comparison 1) was performed on the CBF and resting pH.
To investigate the relationship between cerebral vascular dilation
and pH in skeletal muscle after physical challenge, the time and mag-
nitude of the fMRI characteristic peak (marked out on Fig. 1c) were
linearly regressed against the recovered pH measured after plantar
ﬂexion cycles (comparisons 2 and 3).
3. Results
The dataset showing the mean fMRI signals averaged across the
subjects is shown in Fig. 1c and shows the multiple phases seen in
the expected BP response during the performance of the VM.
Resting cerebral blood ﬂow (CBF) in the CFS patients was signiﬁ-
cantly inversely correlated with skeletal muscle resting pH measured
during the baseline period (Fig. 3, r=−0.67, corrected pb0.01) indi-
cating that a higher acidity within the skeletal muscle at rest was as-
sociated with increased CBF.
When we explored the responses during the VM, there was also
signiﬁcant correlation (Fig. 4, r=0.69, corrected pb0.008) between
the vascular dilation sympathetic peak time (marked by ‘x’ in
Fig. 1c, corresponding to the time of maximal vascular dilation after
VM), and the recovered pH (marked as ‘Post-Ex’ Fig. 2a), measured
after a ﬁxed period of recovery at the end of plantar ﬂexion exercise;
this positive correlation indicates that a delayed vascular dilation
peak is associated with a higher (more alkaline) recovered pH.
There was no signiﬁcant correlation between the magnitude of the
sympathetic peak and recovered pH (Fig. 5, r=0.10, corrected p=
NS), indicating that the vascular dilation in sympathetic phase of
the VM is not signiﬁcantly related to recovered skeletal muscle pH.
4. Discussion
This study has found that cerebral vascular control and skeletal
muscle pH regulation are closely related, both at rest and when
responding to dynamic stimulation in CFS patients, pointing to cere-
bral vascular control being affected by autonomic dysfunction.
CFS patients have been shown to have reduced CBF (Biswal et al.,
2011) and higher skeletal muscle pH at rest (Jones et al., 2010). In this
study we have shown a signiﬁcant correlation (Fig. 3) between these
parameters when measured in the same subject.
Since the vascular constriction and dilation are distinctively asso-
ciated with each phase of the physiological responses in VM, the vas-
cular dilation time course measured in the brain using fMRI allows
the identiﬁcation of the four phases. The vascular dilation characteris-
tic peak is at the end of phase IV, where vascular dilation and sympa-
thetic control reach their maximum. We have shown that CFS
patients have higher recovered skeletal muscle pH (more alkaline)
(Jones et al., 2012); and it has been shown that orthostatic intolerance
is associated with prolonged vascular constriction after autonomic
Fig. 2. Shows (a) the schematic protocol for skeletal muscle exercise, and (b) a schematic pH response illustration during a plantar ﬂexion cycle. The skeletal muscle exercise pro-
tocol contained 2 min baseline and three 9.5 min cycles interspersed by 2 min rest. Each cycle consisted of 3 min plantar ﬂexion exercise and 6.5 min recovery period. The resting
pH was measured during the baseline period, marked as “Baseline” in the ﬁgure. The recovered pHwas measured during the rest period, marked as “Post-Ex” in the ﬁgure, after two
plantar ﬂexion cycles to minimise muscular adaptation effects. The period of plantar ﬂexion exercise is marked by the grey window on the pH time course.
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between the recovered pH and the vascular dilation characteristic
peak time.
Although conventionally CFS has been considered to be a diseasewith
primary CNS pathologies and secondary peripheral consequences, our re-
sults point to possible alternative disease mechanisms. It is possible that
CFS is driven by a primary peripheral abnormality that is associated
with secondary central sequelae, where a compromised skeletal muscle
cellular membrane function underpins the observed abnormalities. TheFig. 3. Shows that there is a signiﬁcant correlation between cerebral blood ﬂow (CBF)
measured in brain and the resting pH measured during baseline in skeletal muscle. The
strong negative correlation indicates that in CFS patients higher alkalinity in skeletal
muscle is associated with lower CBF, while higher acidity is associated with higher CBF.blood pH is generally maintained in a very narrow range through gas
composition. Only very limited clinical conditions manifest themselves
through alteredbloodpH. It has been shown that CFS patients often expe-
rience hyperventilation (Bogaerts et al., 2007), indicating acidic pressure
on blood pH, since blood pH modulates breathing activity. However, hy-
perventilation also increases the concentration of oxygen in the blood,
resulting in a vasoconstrictive effect, in turn reducing CBF at rest and
whichwould prolong cerebral vascular constriction after autonomic chal-
lenge. The 31P MRS measures the intracellular pH, where CFS patients
showed higher pH (more alkaline) both at rest (Jones et al., 2010) and
after aﬁxed recovery period (Jones et al., 2012). The pH in skeletalmuscleFig. 4. Shows the signiﬁcant correlation between the cerebral vascular dilation charac-
teristic peak time and the recovered pH measured during the rest between plantar cy-
cles (shown in Fig. 2). The positive correlation indicates that an earlier cerebral
vascular dilation peak related to sympathetic function is associated with a lower recov-
ered pH.
Fig. 5. Shows the non-signiﬁcant relationship between the cerebral vascular dilation charac-
teristic peakmagnitude and the recovered pHmeasured during the rest between plantar cy-
cles (shown in Fig. 2).
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pH (more alkaline). We postulate that a compromised skeletal muscle
cellular membrane function may lead to the equalisation of the pH be-
tween the skeletal muscle intracellular environment and blood, where
an increase in intracellular pH (more alkaline) and decrease in blood
pH (acidosis) take place, triggering hyperventilation to buffer the pH
change in the blood. Furthermore, we have also shown that the nadir
pH (Fig. 2b) during plantar ﬂexion cycle is reduced (more acidic) in CFS
patients, while its recovery to baseline is slower (Jones et al., 2012).
This is in agreement with the suggestion that increased oxygen concen-
tration in the blood (hyperoxia) compromises the vasodilation, aggravat-
ing acid accumulation and reducing the ability of waste removal. It has
also been shown that plasma lipid peroxidation is elevated inCFSpatients
(Brkic et al., 2010), indicating a poormembrane integrity. It has also been
shown that supplements of essential fatty acids can relieve the symptoms
in CFS patients (Warren et al., 1999), while antioxidant supplements
have been shown to be effective in the animal model (Singh et al.,
2002). However, blood acidosis may also affect cellular membrane func-
tion, hence the underpinning mechanism of CFS cannot be fully resolved
directly in this work, and extensive further work with detailed blood
composition analysis is necessary to validate the pathophysiological
model implicated here. Nevertheless, our results point to a diseasemech-
anism outside of the CNS, with a peripheral cause.
Despite the current lack of consensus as to the underlying biolog-
ical basis of CFS, there is considerable evidence, we believe supported
by the current study, to highlight an abnormality of the autonomic
nervous system as a unifying pathological factor. However, studies
have suggested that in those with CFS there are other established as-
pects of this illness, including HPA-axis abnormalities (Cleare et al.,
2001), central sensitization (Meeus and Nijs, 2007) and cognitive
problems (Beaumont et al., 2012). Our ﬁndings of the changes in vas-
cular control could provide the underpinning abnormality that ex-
plains these apparently disparate problems experienced by those
with CFS.
There is no control group in this study. However, there is a wealth
of literature showing that CFS patients have abnormal vascular con-
trol, as well as abnormal skeletal muscle pH management. The pur-
pose of this study was to examine whether these two abnormalities
are related to each other. Since these abnormalities are well known
and documented, the absence of a control group does not affect the
conclusions of this study. Despite the fact that the number of patients
enrolled in this study was not large, the strength of the correlations
presented in this work is high, indicating the close relationship be-
tween the examined parameters. CFS is a heterogeneous disorder interms of pathophysiology. Our results provide initial evidence that
there is a commonality in terms of the characteristics of CFS. Despite
heterogeneity, it is recognised that CFS patients often suffer from au-
tonomic dysfunction and skeletal muscle pH abnormality. Our results
show that these common abnormalities in CFS are closely linked in
the patient cohort studied. However, larger scale studies should be
commenced to examine the effects of heterogeneity on the observed
relationships. Although the results presented in this work, in conjunc-
tion with literature ﬁndings, point towards alternative disease mech-
anisms, the results are correlative and do not prove a causal
relationship. These drawbacks warrant further investigations on the
direction initiated by this work.
This study is not only informative from scientiﬁc point of view, but
also provides foundation for clinical management of CFS. The VM is a
standard autonomic function challenge inducing large variations in
systemic BP. Since CFS patients often suffer from autonomic function
abnormalities and orthostatic intolerance in daily life, the VM pro-
vides a useful tool to explore the effects of autonomic/orthostatic
challenges. CBF is a key indicator of cerebral function, providing a
marker for cerebral wellbeing affecting daily life. In this work, we ex-
plored the impact of autonomic challenge on key indicator of brain
health, through the combination of VM and blood ﬂowmeasurement.
It is clear from this work that cerebral vascular control and skeletal
muscle pHmanagement are closely related, both at rest and after dynam-
ic stimulation in CFS patients, indicating a strong inﬂuence of autonomic
dysfunction on cerebral vascular control, However, further studies are re-
quired to fully appreciate the underlying pathology of CFS, especially CBF,
oxygenation level measurement during VM and skeletal muscle perfu-
sion measurement during rest and plantar ﬂexion exercise.Acknowledgment
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